Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
about
Revisiting annual screening for latent tuberculosis infection in healthcare workers: a cost-effectiveness analysis.In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection.Tuberculosis screening at the Sainte-Anne Hospital in Paris - results of first and second IGRA.Incidence of occupational latent tuberculosis infection in South African healthcare workers.The seasonality of tuberculosis, sunlight, vitamin D, and household crowding.Occupational screening for tuberculosis and the use of a borderline zone for interpretation of the IGRA in German healthcare workers.The dynamics of QuantiFERON-TB gold in-tube conversion and reversion in a cohort of South African adolescents.Cough Aerosol Cultures of Mycobacterium tuberculosis: Insights on TST / IGRA Discordance and Transmission DynamicsChallenges with QuantiFERON-TB Gold assay for large-scale, routine screening of U.S. healthcare workers.Serial IGRA testing of trainees in the healthcare sector in a country with low incidence for tuberculosis - a prospective cohort study.Gamma interferon release assays for detection of Mycobacterium tuberculosis infection.QFT-Plus: a plus in variability? - Evaluation of new generation IGRA in serial testing of students with a migration background in GermanyTuberculosis in healthcare workers - a narrative review from a German perspectiveIFN-γ release assay conversions and reversions. Challenges with serial testing in U.S. health care workers.Tuberculosis in liver transplant recipients: experience of a South Indian liver transplant center.Evaluation of QuantiFERON-TB Gold-Plus in Health Care Workers in a Low-Incidence Setting.Serial testing for latent tuberculosis infection in transplant candidates: a retrospective review.Interferon-γ release assay vs. tuberculin skin test for tuberculosis screening in exposed healthcare workers: a longitudinal multicenter comparative study.Serial testing for latent tuberculosis using QuantiFERON-TB Gold In-Tube: A Markov model.T-SPOT.TB Interferon-γ Release Assay Performance in Healthcare Worker Screening at Nineteen U.S. Hospitals.Prevention of anti-tumor necrosis factor-associated tuberculosis: a 10-year longitudinal cohort study.Comparative analysis of assays for detection of cell-mediated immunity toward cytomegalovirus and M. tuberculosis in samples from deceased organ donors.Interferon-gamma release assay for the diagnosis of latent tuberculosis infection: A latent-class analysis.Cumulative False-Positive QuantiFERON-TB Interferon-γ Release Assay Results.Tuberculin skin test conversions and occupational exposure risk in US healthcare workers.Occupational Screening for Tuberculosis. A Testing Time for Interferon-γ Release Assays
P2860
Q33702764-74AD5B4A-D81F-4CFC-85F4-C93EF76FA58EQ33824247-D9FB053C-12D7-4AB4-8FA7-824558031831Q33890563-DFACBD64-7D72-42E5-9DDE-003C23C8ED1AQ33924856-4E67C38C-004D-4F77-B831-153CA61623D3Q34034066-B5B68F62-A9E9-45E3-BB85-4E9684350ACAQ34776030-407482BC-0B23-4A6B-BFA6-D8387A15D72CQ35261953-01674FC1-F222-4B79-B7FA-1B3581175C99Q35783572-FC9418FE-E420-41BC-BE16-127865B1052BQ37304401-8C418C40-6A6D-4651-9435-6AE6B98FBDBEQ37378565-B870D812-2040-4CCE-8FCE-B90BAF9EACACQ37544916-28368706-3AAD-4CC7-B9BF-21B53BEDF54AQ37563933-AF5BC5F4-BDE2-494A-AF48-C74B4CBB5B56Q37699705-28076304-56A7-4C45-8ADA-D001A2F89BB1Q38180469-7B2B5C6D-0E37-472D-8D8D-5F6533374434Q38208758-415FA302-734C-4865-A13E-5D4F3FD396E8Q38404818-023A2C1B-223B-49FE-B8B8-40746E089D55Q38670287-47AD68BF-A6E1-4406-AE89-AB0F0A04E3CFQ39192959-BFFCC5D0-8C1E-4B3F-BBB5-09991DAE1FAFQ40596209-D033430C-424E-4486-B4BF-1981C36D1B9BQ40897243-DAEFA9E8-A361-41F8-ABC3-D95C891040A6Q41702217-803687D7-1260-4E44-AFF7-8CBEDCD787DBQ42205166-15EFAB0A-7C57-414B-AE0E-1381F41AB204Q47158308-0CF2CFA9-D409-4E28-A0AA-7A76EABE90C8Q48066031-F9A60D82-BE32-4806-A5BA-964AAEDE6CE4Q50064979-6F2D13A1-738E-48D9-9CEA-084B7D3A3781Q59200599-E004F64B-87E7-4731-BE4F-899191A9B615
P2860
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
@ast
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
@en
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
@en-gb
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
@nl
type
label
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
@ast
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
@en
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
@en-gb
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
@nl
altLabel
Repeat IGRA Testing in Canadian Health Workers: Conversions or Unexplained Variability?
@en
prefLabel
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
@ast
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
@en
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
@en-gb
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
@nl
P2093
P2860
P3181
P1433
P1476
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?
@en
P2093
Alice Zwerling
Andrea Benedetti
Filomena Pietrangelo
Fiona McIntosh
Kevin Schwartzman
Marcel A Behr
Mihaela Cojocariu
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0054748
P407
P577
2013-01-01T00:00:00Z